Startup profile · funding coverage
Fundly.ai funding, valuation and investors
B2B pharma commerce, payments, and embedded credit for India’s retail and distributor supply chain.
Verified company research · funding, investors and latest developments
Keep track of Fundly.ai
Save this profile to your VCT watchlist for a quick return.
Funding, valuation & investors
Answer-first snapshotLatest funding
Seed
$3M · 2023
Latest known valuation
Not publicly disclosed
Total disclosed equity funding
$3M
Excludes debt, grants, acquisitions, secondaries, and IPO proceeds.
Current status
private
series a · Mumbai, India
Investors in latest funding
Lead: Accel
Other: Multiply Ventures
Latest tracked event: Equity + venture debt (September 2026). It is shown separately because it is not counted as disclosed equity funding.
Overview
Mumbai-based Fundly.ai, founded in 2021 by Amit Chawla and Shreeram Ramanathan, started in pharma supply-chain financing and now combines B2B commerce, payments/settlement, and embedded credit for retailers and distributors.
Indian Startup Times reported a September 8, 2026 financing of about $4 million equity led by existing investors Accel and Multiply Ventures, with former RBL Bank executive director Rajeev Ahuja and other angels, plus roughly $0.9 million venture debt (~$4.9 million combined). Prior Accel-led seed was $3 million in 2023.
Why Fundly.ai is interesting
September 8, 2026 ~$4M equity led by Accel and Multiply Ventures plus ~$0.9M venture debt (~$4.9M total) — Accel doubling down after a 2023 $3M seed as Fundly expands from supply-chain finance into full-stack pharma distribution rails.
Product & use cases
Digital procurement, settlement, and credit tools for pharma retailers and distributors that previously ran on fragmented financing and offline ordering.
- Pharma retailer procurement and working-capital access
- Distributor payments and settlement automation
- Embedded credit against trade flows in the pharma supply chain
Key facts
- ~$4M equity led by Accel + Multiply Ventures; ~$0.9M venture debt (~$4.9M total) — Sep 8, 2026
- Builds on Accel-led $3M seed (2023)
- Product stack: B2B commerce + payments + embedded working-capital credit for pharma retail/distribution
Funding history (newest first)
Equity + venture debt
2026-09 ~$4.9M ($4M equity + $0.9M debt)- Accel (lead)
- Multiply Ventures (lead)
- Rajeev Ahuja (participant)
Seed
2023 $3M- Accel (lead)
- Multiply Ventures (participant)
Industries
Market / IPO context
Editorial / static context — not a live quote.
Last updated:
Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.